Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Return on Investment 2010-2023 | MKGAF

Current and historical return on investment (ROI) values for Merck (MKGAF) over the last 10 years.
  
Merck ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2023-12-31 $3.91B $38.96B 9.91%
2023-09-30 $4.14B $41.18B 10.64%
2023-06-30 $4.32B $39.55B 11.32%
2023-03-31 $4.51B $37.99B 11.97%
2022-12-31 $4.71B $37.09B 12.76%
2022-09-30 $5.00B $37.87B 13.71%
2022-06-30 $4.99B $37.69B 14.05%
2022-03-31 $5.00B $35.10B 14.49%
2021-12-31 $4.94B $35.12B 14.46%
2021-09-30 $4.47B $34.05B 13.53%
2021-06-30 $4.60B $33.84B 15.42%
2021-03-31 $3.88B $33.74B 13.32%
2020-12-31 $3.41B $30.62B 11.93%
2020-09-30 $3.27B $21.11B 11.51%
2020-06-30 $2.58B $30.95B 8.45%
2020-03-31 $2.74B $31.70B 9.25%
2019-12-31 $2.37B $29.75B 8.45%
2019-09-30 $2.16B $29.80B 7.80%
2019-06-30 $2.06B $27.06B 7.67%
2019-03-31 $1.83B $25.81B 6.81%
2018-12-31 $2.04B $28.24B 7.49%
2018-09-30 $1.98B $26.09B 7.50%
2018-06-30 $2.47B $27.41B 9.38%
2018-03-31 $2.69B $27.09B 10.55%
2017-12-31 $2.86B $24.98B 11.52%
2017-09-30 $2.99B $25.69B 12.02%
2017-06-30 $2.68B $24.11B 10.97%
2017-03-31 $2.61B $24.34B 10.59%
2016-12-31 $2.75B $25.30B 11.15%
2016-09-30 $2.64B $24.08B 10.77%
2016-06-30 $2.53B $25.02B 10.15%
2016-03-31 $2.46B $24.08B 10.08%
2015-12-31 $2.10B $24.94B 8.62%
2015-09-30 $1.88B $25.79B 8.10%
2015-06-30 $1.81B $22.99B 8.44%
2015-03-31 $1.76B $23.76B 8.71%
2014-12-31 $1.83B $20.42B 9.75%
2014-09-30 $2.26B $18.51B 12.26%
2014-06-30 $2.52B $18.04B 13.66%
2014-03-31 $2.88B $18.04B 15.64%
2013-12-31 $2.88B $19.03B 15.57%
2013-09-30 $5.99B $18.62B 32.93%
2013-06-30 $5.76B $18.07B 42.57%
2013-03-31 $4.97B $18.33B 55.13%
2012-12-31 $7.60B $17.72B 171.58%
2012-09-30 $7.27B inf%
2012-06-30 $10.25B inf%
2012-03-31 $10.32B inf%
2011-12-31 $10.55B inf%
2011-09-30 $10.95B inf%
2011-06-30 $7.98B inf%
2011-03-31 $10.53B inf%
2010-12-31 $9.81B inf%
2010-09-30 $9.09B inf%
2010-06-30 $11.25B inf%
2010-03-31 $11.14B inf%
2009-12-31 $10.81B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $22.335B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.055B 31.33
Chugai Pharmaceutical (CHGCY) Japan $50.402B 22.53
Takeda Pharmaceutical (TAK) Japan $42.567B 8.62
Astellas Pharma (ALPMY) Japan $17.626B 27.83
Sandoz Group AG (SDZNY) Switzerland $15.210B 0.00
Neurocrine Biosciences (NBIX) United States $13.936B 38.15
Shionogi (SGIOY) Japan $13.831B 12.02
United Therapeutics (UTHR) United States $11.966B 12.76
Catalent (CTLT) United States $10.048B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.670B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.061B 7.76
Revolution Medicines (RVMD) United States $6.167B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.586B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.496B 0.00
Alpine Immune Sciences (ALPN) United States $4.455B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.894B 0.00
Summit Therapeutics (SMMT) United States $3.289B 0.00
Corcept Therapeutics (CORT) United States $2.880B 26.09
Arrowhead Pharmaceuticals (ARWR) United States $2.845B 0.00
Dyne Therapeutics (DYN) United States $2.461B 0.00
Indivior (INDV) United States $2.417B 11.46
PTC Therapeutics (PTCT) United States $2.391B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.358B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.103B 12.02
Evotec AG (EVO) Germany $1.967B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.948B 18.95
NewAmsterdam Pharma (NAMS) Netherlands $1.830B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.823B 0.00
Ardelyx (ARDX) United States $1.813B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.591B 27.85
Avadel Pharmaceuticals (AVDL) Ireland $1.460B 0.00
Soleno Therapeutics (SLNO) United States $1.453B 0.00
Pacira BioSciences (PCRX) United States $1.435B 13.64
4D Molecular Therapeutics (FDMT) United States $1.331B 0.00
Xencor (XNCR) United States $1.255B 0.00
Enliven Therapeutics (ELVN) United States $1.122B 0.00
Cronos Group (CRON) Canada $1.119B 0.00
Cassava Sciences (SAVA) United States $1.119B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.106B 0.00
Collegium Pharmaceutical (COLL) United States $1.089B 6.51
Ironwood Pharmaceuticals (IRWD) United States $1.038B 16.17
Centessa Pharmaceuticals (CNTA) United Kingdom $1.022B 0.00
ProKidney (PROK) United States $0.945B 0.00
Ocular Therapeutix (OCUL) United States $0.937B 0.00
USANA Health Sciences (USNA) United States $0.906B 14.82
ARS Pharmaceuticals (SPRY) United States $0.870B 0.00
Relay Therapeutics (RLAY) United States $0.844B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.742B 0.00
Sage Therapeutics (SAGE) United States $0.722B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.673B 0.00
Savara (SVRA) United States $0.665B 0.00
Lyell Immunopharma (LYEL) United States $0.648B 0.00
Silence Therapeutics (SLN) United Kingdom $0.633B 0.00
Exscientia (EXAI) United Kingdom $0.603B 0.00
Harrow (HROW) United States $0.575B 0.00
Siga Technologies (SIGA) United States $0.558B 7.14
Altimmune (ALT) United States $0.554B 0.00
OmniAb (OABI) United States $0.527B 0.00
KalVista Pharmaceuticals (KALV) United States $0.527B 0.00
Verve Therapeutics (VERV) United States $0.523B 0.00
Larimar Therapeutics (LRMR) United States $0.503B 0.00
Bioventus (BVS) United States $0.474B 18.15
Lexeo Therapeutics (LXEO) United States $0.460B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.459B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.456B 0.00
Heron Therapeutics (HRTX) United States $0.423B 0.00
Esperion Therapeutics (ESPR) United States $0.413B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.403B 0.00
Korro Bio (KRRO) United States $0.402B 0.00
Organogenesis (ORGO) United States $0.377B 71.12
Tourmaline Bio (TRML) United States $0.370B 0.00
Nanobiotix S.A (NBTX) France $0.344B 0.00
Nektar Therapeutics (NKTR) United States $0.325B 0.00
Black Diamond Therapeutics (BDTX) United States $0.323B 0.00
Fractyl Health (GUTS) United States $0.317B 0.00
Nature's Sunshine Products (NATR) United States $0.294B 18.70
Aquestive Therapeutics (AQST) United States $0.291B 0.00
Xeris Biopharma Holdings (XERS) United States $0.282B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.280B 0.00
ESSA Pharma (EPIX) Canada $0.265B 0.00
Akebia Therapeutics (AKBA) United States $0.258B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
Pyxis Oncology (PYXS) United States $0.247B 0.00
Metagenomi (MGX) United States $0.245B 0.00
Foghorn Therapeutics (FHTX) United States $0.241B 0.00
Eliem Therapeutics (ELYM) United States $0.227B 0.00
Avita Medical (RCEL) United States $0.225B 0.00
Conduit Pharmaceuticals (CDT) United States $0.210B 0.00
Century Therapeutics (IPSC) United States $0.204B 0.00
Zevra Therapeutics (ZVRA) United States $0.201B 0.00
Profound Medical (PROF) Canada $0.201B 0.00
Adherex Technologies (FENC) United States $0.201B 244.67
Incannex Healthcare (IXHL) Australia $0.194B 0.00
Acrivon Therapeutics (ACRV) United States $0.189B 0.00
Telomir Pharmaceuticals (TELO) United States $0.187B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Galectin Therapeutics (GALT) United States $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.172B 0.00
MediWound (MDWD) Israel $0.169B 0.00
CytoDyn (CYDY) United States $0.167B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.166B 0.00
Prelude Therapeutics (PRLD) United States $0.162B 0.00
VAXART, INC (VXRT) United States $0.153B 0.00
Elite Pharmaceuticals (ELTP) United States $0.149B 13.95
Cardiol Therapeutics (CRDL) Canada $0.149B 0.00
Regulus Therapeutics (RGLS) United States $0.136B 0.00
Karyopharm Therapeutics (KPTI) United States $0.128B 0.00
Context Therapeutics (CNTX) United States $0.128B 0.00
OptiNose (OPTN) United States $0.128B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.127B 8.50
FibroGen (FGEN) United States $0.117B 0.00
PMV Pharmaceuticals (PMVP) United States $0.110B 0.00
Relmada Therapeutics (RLMD) United States $0.110B 0.00
Citius Pharmaceuticals (CTXR) United States $0.109B 0.00
Vivani Medical (VANI) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.096B 4.39
AlloVir (ALVR) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Jaguar Animal Health (JAGX) United States $0.076B 0.00
Tempest Therapeutics (TPST) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.074B 1.05
Marinus Pharmaceuticals (MRNS) United States $0.074B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Protara Therapeutics (TARA) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Carisma Therapeutics (CARM) United States $0.061B 0.00
Inotiv (NOTV) United States $0.055B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
BioLineRx (BLRX) Israel $0.052B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.051B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
Gain Therapeutics (GANX) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.042B 0.00
Unicycive Therapeutics (UNCY) United States $0.041B 0.00
Nutriband (NTRB) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.035B 0.00
NRx Pharmaceuticals (NRXP) United States $0.034B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
Lipocine (LPCN) United States $0.029B 0.00
DURECT (DRRX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
JanOne (JAN) United States $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
Lyra Therapeutics (LYRA) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.021B 0.81
PolyPid (PYPD) Israel $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.013B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 36.17